Participation in two phase II prophylactic HIV vaccine trials in the UK-Reference-Cited by-同舟云学术

Participation in two phase II prophylactic HIV vaccine trials in the UK

Published:2008-06 Issue:23 Volume:26 Page:2919-2924
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Gray Kimberly,Legg K.,Sharp A.,Mackie N.,Olarinde F.,De Souza C.,Weber J.,Peters B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference28 articles.

1. UNAIDS, AIDS epidemic update: a special report on HIV/AIDS: December 2006, Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2006, http://www.unaids.org/en/HIV_data/epi2006.

2. Promising AIDS vaccine's failure leaves field reeling;Cohen;Science,2007

3. International AIDS Vaccine Initiative (IAVI). IAVI Database of AIDS Vaccines in Human Trials. IAVI, February 22; 2008, http://www.iavireport.org/trialsdb/searchresults4.asp?list=vaccine&ts=.&vt=.

4. Past, present and future of HIV vaccine trials in developing countries;Esparza;Vaccine,2002

5. The need for a global HIV vaccine enterprise;Klausner;Science,2003

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why do people take part in vaccine trials? A mixed methods narrative synthesis;Patient Education and Counseling;2023-09

2. Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials;JAIDS Journal of Acquired Immune Deficiency Syndromes;2018-10-01

3. Typologies of Altruistic and Financial Motivations for Research Participation;Journal of Empirical Research on Human Research Ethics;2016-10

4. Accelerating clinical development of HIV vaccine strategies: methodological challenges and considerations in constructing an optimised multi-arm phase I/II trial design;Trials;2014-02-26

5. Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial;BMC Public Health;2013-12